Purpose The Hospital Authority Healthcare Technology Assessment Report (HAHTA Report) is prepared by the Clinical Effectiveness Unit (CEU) to provide current, accurate and usable information on technical efficiency, safety and efficacy of new / evolving health technologies that have potential applications in Hong Kong. Comparison will be made, whenever possible, with the current standard practi...

In the past 20 years, there has been increasing recognition of the need to consider cost in medical decision making. This period has seen an explosion in the number of economic evaluations appearing in the medical literature. Cost-effectiveness analysis is an objective systematic technique for comparing alternative health care strategies on both cost and effectiveness simultaneously. Cost-effec...

The state of Louisiana, like the nation as a whole, is facing the salient challenge of improving population health and efficiency of healthcare delivery. Research to inform innovations in healthcare will best enhance this effort if it is timely, efficient, and patient-centered. The Louisiana Clinical Data Research Network (LACDRN) will increase the capacity to conduct robust comparative effecti...

TNF inhibitors are currently considered both effective and cost-effective in patients with active rheumatoid arthritis (RA), particularly in patients who have not responded fully to methotrexate. There is substantial doubt about the cost-effectiveness of TNF inhibitors as initial treatment for active RA. New data from the National Data Bank for Rheumatic Diseases now question the current consen...